Stay informed with the latest litigation news. Explore now

Patent opposition analysis in respiratory drugs industry

In the competitive field of respiratory drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in respiratory drugs technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the respiratory drugs Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the respiratory drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the respiratory drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the respiratory drugs industry

Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA KIRINJul 16, 2025J A KEMP
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA HAKKO KIRINJul 15, 2025ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB
Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSJun 23, 2025AMGEN
Use Of Substituted Aminopropionate Compounds In Treatment Of Sars-Cov-2 InfectionACADEMY OF MILITARY MEDICAL SCIENCESJun 18, 2025GILEAD SCIENCES
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025BRULIE
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 26, 2025KRKA
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 20, 2025HAMM & WITTKOPP
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025RATIOPHARM
Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025GENERICS UK

To stay ahead in the competitive respiratory drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the respiratory drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
May 13, 2020Methods Of Administering Pirfenidone TherapyINTERMUNE6
Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS6
Mar 29, 2017Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES6
Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUP5
Dec 11, 2019Administration Of Gamma Hydroxybutyrate With Monocarboxylate TransportersJAZZ PHARMACEUTICALS IRELAND4
Jun 30, 2021Method Of Providing Pirfenidone Therapy To A PatientINTERMUNE4
May 20, 2020Methods Of Administering Fluvoxamine TherapyINTERMUNE4